(Q28139460)

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomeres shorten during ageing of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Human telomerase contains evolutionarily conserved catalytic and structural subunits

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomere reduction in human colorectal carcinoma and with ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomerase activation by the E6 gene product of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomerase catalytic subunit homologs from fission yeast and human

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Telomeres and telomerase in normal and malignant haematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Developmental and tissue-specific regulation of mouse telomerase and telomere length

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Genes coding for tumor antigens recognized by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021

Expression of mage genes by non-small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980066-7

7 January 2021